Cargando…

HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies

Multiple oncogenic molecular alterations have been discovered that serve as potential drug targets in non-small cell lung cancer (NSCLC). While the pathogenic and pharmacological features of common targets in NSCLC have been widely investigated, those of uncommon targets are still needed to be clari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xin, Ji, Xianxiu, Su, Chunxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002096/ https://www.ncbi.nlm.nih.gov/pubmed/35425713 http://dx.doi.org/10.3389/fonc.2022.860313

Ejemplares similares

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer
por: Han, Yanjie, et al.
Publicado: (2023)

Research Progress on the Microenvironment and Immunotherapy of Advanced Non-Small Cell Lung Cancer With Liver Metastases
por: Fang, Yujia, et al.
Publicado: (2022)

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study
por: Shi, Jiajie, et al.
Publicado: (2023)

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component
por: Li, Peng, et al.
Publicado: (2022)

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features
por: Sompallae, Ramakrishna R., et al.
Publicado: (2023)

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study
por: Song, Zhengbo, et al.
Publicado: (2021)

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients
por: Wang, Jinhao, et al.
Publicado: (2023)

Imaging and Clinicopathological Features of Acinar Cell Carcinoma
por: Qu, Qianqian, et al.
Publicado: (2022)

Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features
por: Wen, Qiang, et al.
Publicado: (2021)

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series
por: Zhao, Shuang, et al.
Publicado: (2021)

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study
por: İlhan, Aysegul, et al.
Publicado: (2023)

Clinicopathological features of papillary thyroid carcinoma in HIV-infected patients
por: Liu, Jia, et al.
Publicado: (2023)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Clinicopathological and CT features of tumor spread through air space in invasive lung adenocarcinoma
por: Qin, Lili, et al.
Publicado: (2022)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Correlation between gene mutation status and clinicopathologic features in early multiple primary lung cancer
por: Teng, Fei, et al.
Publicado: (2023)

Computed Tomography Features and Clinicopathological Characteristics of Gastric Sarcomatoid Carcinoma
por: Liu, Yi-yang, et al.
Publicado: (2020)

Lung Cancer in Non-Smokers: Clinicopathological and Survival Differences from Smokers
por: Vasudevan, Smreti, et al.
Publicado: (2022)

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
por: Ambrosini-Spaltro, Andrea, et al.
Publicado: (2023)

Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
por: Long, Zhiping, et al.
Publicado: (2020)

NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics
por: Moreno, Vanessa, et al.
Publicado: (2022)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer—A Clinicopathological Series
por: Alves, Marclesson, et al.
Publicado: (2021)

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations
por: Jia, Yijun, et al.
Publicado: (2020)

PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer
por: Ji, Yong, et al.
Publicado: (2014)

Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
por: Guan, Wen-Long, et al.
Publicado: (2020)

Clinicopathologic features, treatment, and prognosis of pregnancy-associated breast cancer
por: Li, Yuechong, et al.
Publicado: (2022)

Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
por: Xu, Hangcheng, et al.
Publicado: (2022)

Clinicopathological features and prognosis of patients with HER2-low breast cancer
por: Yang, Xin, et al.
Publicado: (2023)

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
por: Xie, Mingying, et al.
Publicado: (2021)

The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
por: Yan, Tinghao, et al.
Publicado: (2022)

Different clinical features between patients with ROS1-positive and ALK-positive advanced non-small cell lung cancer
por: Ji, Xianxiu, et al.
Publicado: (2021)

Clinicopathological Features and Prognoses in Patients With Brain Metastases From Small-Cell Esophageal Carcinoma: A Retrospective Analysis of 18 Patients
por: Jiao, Wenpeng, et al.
Publicado: (2021)

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer
por: Kim, Kangjoon, et al.
Publicado: (2023)

The expression and biological effect of NR2F6 in non-small cell lung cancer
por: Yang, Shu lin, et al.
Publicado: (2022)

HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
por: Uy, Natalie F., et al.
Publicado: (2022)

Augmented Features Synergize Radiomics in Post-Operative Survival Prediction and Adjuvant Therapy Recommendation for Non-Small Cell Lung Cancer
por: Chan, Lawrence Wing-Chi, et al.
Publicado: (2022)

Maintenance Therapies for Non-Small Cell Lung Cancer
por: Blais, Normand, et al.
Publicado: (2014)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6lctkfvgmfs1qg6oov6e4c3dn